Yilu Lin

10PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Major global burdens of diseaseEpidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 14, 2025
Healthcare cost comparison between first-line ibrutinib and acalabrutinib in chronic lymphocytic leukemia patients in the Veterans Affairs.

Lindsey Fitzgerald, Sabyasachi Ghosh, Alex Bokun

|Jun 11, 2025
Long-Term Testosterone Shows Cardiovascular Safety in Men With Testosterone Deficiency in Electronic Health Records.

Yilu Lin, Shaveta Gupta, Lizheng Shi

|Dec 13, 2024
Epidemiology and burden of focal segmental glomerulosclerosis among United States Veterans: An analysis of Veteran's Affairs data.

Deborah Goldschmidt, Mark E Bensink, Zheng-Yi Zhou

|Oct 26, 2024
Overall Survival in Real-World Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Versus Sorafenib or Lenvatinib as First-Line Therapy: Findings from the National Veterans Health Administration Database.

David E Kaplan, Ruoding Tan, Cheryl Xiang

|Feb 01, 2024
Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data.

Tianze Jiao, Hamed Kianmehr, Yilu Lin

|Jun 19, 2023
A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States.

Yilu Lin, Hui Shao, Vivian Fonseca

Pageof 2

Frequent Collaborators

7 joint publications

Lizheng Shi

4 joint publications

Vivian Fonseca

3 joint publications

Hui Shao

1 joint publications

Solomon A Graf